India, Nov. 17 -- Sai Parenterals Limited, through its wholly owned subsidiary SP Analytics Private Limited, has signed a definitive agreement to acquire a majority stake in Hyderabad-based Bion Therapeutics India Private Limited. The all-cash transaction is expected to be completed before the end of November 2026, following which Bion will become a step-down subsidiary of Sai Parenterals.

Founded in 2005, Bion Therapeutics operates in the branded prescription formulations segment across 12 states, with a strong presence in South, East and Northeast India. Its portfolio comprises 16 branded formulations across therapeutic segments, including neuropathy, diabetes supportive care, mitochondrial health, wound care and pain management.

The co...